GDF-3 Activators
GDF-3 activators encompass a spectrum of chemical compounds that elevate the functional capacity of GDF-3, a member of the TGF-β superfamily involved in embryogenesis and development. Retinoic acid, for instance, by modulating the cellular retinoic acid pathway, indirectly fortifies GDF-3 signaling, pivotal for cellular differentiation. Lithium Chloride, through Wnt pathway activation via GSK-3β inhibition, may augment GDF-3's developmental regulatory roles. Similarly, inhibitors like SB431542 and A8301 target TGF-β type I receptors, potentially amplifying GDF-3 activity by disrupting negative feedback loops within its signaling network. Compounds such as Dorsomorphin and LDN-193189 serve to indirectly bolster GDF-3's function by perturbing the BMP signaling equilibrium, suggestiveof a compensatory enhancement of GDF-3's role in similar pathways. Additionally, Forskolin, by raising cAMP, activates PKA, which may phosphorylate SMAD proteins to potentiate GDF-3's involvement in cellular differentiation. Rapamycin's inhibition of mTOR could facilitate an increase in GDF-3 activity by minimizing suppressive cross-talk with growth and differentiation signals. Further, the MEK inhibitor PD98059 might indirectly augment GDF-3 signaling by tempering the MAPK/ERK pathway, which interacts with GDF-3's SMAD-dependent mechanisms.
In the realm of cellular stress response modulation, SP600125 inhibits the JNK pathway, potentially shifting signaling dynamics to favor GDF-3 activity. LY294002 disrupts PI3K signaling, thereby potentially removing inhibitory influences on GDF-3's regulatory functions related to survival and proliferation. Y-27632's inhibition of ROCK alters cytoskeletal dynamics, which can indirectly promote GDF-3 signaling pathways. Collectively, these chemical agents employ diverse strategies to enhance GDF-3 signaling, each acting on distinct but interconnected pathways that converge on the pivotal role of GDF-3 in controlling cellular processes critical for development and differentiation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences the cellular retinoic acid signaling pathway, which can interact with the SMAD signaling pathway integral to GDF-3 signaling, thus potentially enhancing GDF-3's role in cellular differentiation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride activates the Wnt signaling pathway through the inhibition of GSK-3β, which can lead to the stabilization of β-catenin, a process that may upregulate GDF-3 activity in the regulation of embryonic development. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β type I receptor ALK5, which when inhibited may enhance GDF-3 signaling by relieving negative feedback mechanisms within the TGF-β superfamily pathways that GDF-3 is a part of. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $186.00 $751.00 | 28 | |
Dorsomorphin inhibits BMP signaling by targeting the BMP type I receptors ALK2, ALK3, and ALK6, which may lead to compensatory upregulation of GDF-3 activity as part of homeostatic balance within the BMP pathway. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
LDN-193189 is a selective BMP signaling inhibitor that acts on ALK2 and ALK3. Similar to Dorsomorphin, it may indirectly enhance GDF-3 activity by affecting the BMP signaling balance. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can lead to the activation of PKA. PKA may then phosphorylate SMAD proteins, enhancing GDF-3 signaling involved in differentiation and development. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation. This inhibition may enhance GDF-3 signaling related to growth inhibition and differentiation by reducing mTOR's suppressive effects on these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that may upregulate GDF-3 activity by inhibiting the MAPK/ERK pathway, which can have cross-talk with GDF-3's SMAD-dependent signaling, thus indirectly enhancing GDF-3 function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits the JNK pathway, which may enhance GDF-3 activity by altering the stress response signaling dynamics that can influence the SMAD pathways associated with GDF-3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and its action may lead to enhanced GDF-3 activity by affecting cellular survival and proliferation pathways that intersect with GDF-3's regulatory functions. | ||||||